# Enlaza Therapeutics, Inc. — Form D/A

Enlaza Therapeutics, Inc. of LA JOLLA, CA, a company, filed a Form D amendment with the SEC on 2022-11-22. The offering totals $61.3M, of which $35.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-11-22
- Form: D/A
- Accession: 0001852950-22-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $61.3M
- Amount sold: $35.3M
- Remaining: $26.0M
- Investors: 10
- Date of first sale: 2021-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-393460

## Issuer

- Name: Enlaza Therapeutics, Inc.
- CIK: 0001852950
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 11099 NORTH TORREY PINES ROAD, STE. 280, LA JOLLA, CA, 92037
- Phone: 858-348-2180

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Shelley Chu | Director | Lexington, MA |
| Tighe Reardon | Executive Officer | La Jolla, CA |
| Stephen Squinto | Director | Stamford, CT |
| Marcos Milla | Director | La Jolla, CA |
| Jay Lichter | Director | La Jolla, CA |
| Sergio Duron | Director | La Jolla, CA |
| Sergio Duron | Executive Officer | La Jolla, CA |
| James Topper | Director | La Jolla, CA |
| Sanford Madigan | Executive Officer | La Jolla, CA |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-09-11](https://search.stillhousedata.com/formd/0001231919-25-000186) | D | $15.0M | $15.0M |
| [2024-08-09](https://search.stillhousedata.com/formd/0001852950-24-000001) | D | $110.0M | $84.0M |
| [2022-10-13](https://search.stillhousedata.com/formd/0001852950-22-000002) | D | $312K | — |
| [2022-10-13](https://search.stillhousedata.com/formd/0001852950-22-000001) | D | — | — |
| [2021-08-13](https://search.stillhousedata.com/formd/0001852950-21-000003) | D | — | — |
| [2021-06-28](https://search.stillhousedata.com/formd/0001852950-21-000002) | D | — | — |
| [2021-03-25](https://search.stillhousedata.com/formd/0001852950-21-000001) | D | $21.3M | $4.0M |

## More

- [CIK 1852950 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1852950&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001852950-22-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.